Van Leeuwen & Company, LLC Eli Lilly & CO Transaction History

Van Leeuwen & Company, LLC

$196 Million
Q1 2024

A detailed history of Van Leeuwen & Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Van Leeuwen & Company, LLC holds 5,638 shares of LLY stock, worth $4.21 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares

5,638

Previous 5,621 0.3%

Holding current value

$4.21 Million

Previous $3.28 Million 33.88%

% of portfolio

2.24%

Previous 1.92%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $10,067 - $13,468	17 Added 0.3%	5,638 $4.39 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $476,347 - $561,550	-907 Reduced 13.89%	5,621 $3.28 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $618,143 - $852,204	-1,422 Reduced 17.89%	6,528 $3.51 Million
Q2 2023 Feb 06, 2024	BUY	$350.74 - $468.98 $498,752 - $666,889	1,422 Added 21.78%	7,950 $3.73 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $439,126 - $587,162	-1,252 Reduced 13.61%	7,950 $3.67 Million
Q1 2023 Feb 06, 2024	BUY	$310.63 - $364.82 $407,546 - $478,643	1,312 Added 16.63%	9,202 $3.16 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $407,546 - $478,643	1,312 Added 16.63%	9,202 $3.16 Million
Q4 2022 Feb 06, 2024	BUY	$321.55 - $374.67 $437,951 - $510,300	1,362 Added 20.86%	7,890 $2.89 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $67,203 - $78,306	-209 Reduced 2.58%	7,890 $2.89 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $989,946 - $1.13 Million	-3,339 Reduced 29.19%	8,099 $2.62 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $811,104 - $952,355	-2,910 Reduced 20.28%	11,438 $3.71 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $612,071 - $760,649	2,608 Added 22.21%	14,348 $4.11 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.64 Million - $3.28 Million	11,740 New	11,740 $3.24 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $2.18 Million - $2.53 Million	-14,943 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $555,775 - $668,869	4,074 Added 37.48%	14,943 $2.45 Million
Q1 2020 Apr 23, 2020	BUY	$119.05 - $147.35 $942,518 - $1.17 Million	7,917 Added 268.19%	10,869 $1.51 Million
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $315,627 - $390,933	2,952 New	2,952 $388,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Leeuwen & Company, LLC with notifications on news.

Account

Van Leeuwen & Company, LLC Eli Lilly & CO Transaction History